Treatment of central venous occlusion is guided largely by anatomic considerations determined by pre-procedural imaging. Current approaches to imaging such as ultrasound and conventional cross-sectional imaging of central veins face many technical challenges and may be contraindicated in patients with renal impairment. We demonstrated that ferumoxytol-enhanced MR venography (FE-MRV) is a safe and highly accurate diagnostic tool that can be used as a reliable pre-interventional vascular map.
This abstract and the presentation materials are available to members only; a login is required.